Numerous studies have shown a reduction in paraoxonase 1 activity in people with metabolic syndrome [30, 31].At present, more and more factors are being discussed that predispose early to the onset of atherosclerotic lesions and, consequently, to cardiovascular diseases. The gene discussed is PON1; the disease is cardiovascular disorder.